AntimiR-132 Attenuates Myocardial Hypertrophy in an Animal Model of Percutaneous Aortic Constriction.

Journal of the American College of Cardiology
Rabea HinkelChristian Kupatt

Abstract

Pathological cardiac hypertrophy is a result of afterload-increasing pathologies including untreated hypertension and aortic stenosis. It features progressive adverse cardiac remodeling, myocardial dysfunction, capillary rarefaction, and interstitial fibrosis often leading to heart failure. This study aimed to establish a novel porcine model of pressure-overload-induced heart failure and to determine the effect of inhibition of microribonucleic acid 132 (miR-132) on heart failure development in this model. This study developed a novel porcine model of percutaneous aortic constriction by implantation of a percutaneous reduction stent in the thoracic aorta, inducing progressive remodeling at day 56 (d56) after pressure-overload induction. In this study, an antisense oligonucleotide specifically inhibiting miR-132 (antimiR-132), was regionally applied via intracoronary injection at d0 (percutaneous transverse aortic constriction induction) and d28. At d56, antimiR-132 treatment diminished cardiomyocyte cross-sectional area (188.9 ± 2.8 vs. 258.4 ± 9.0 μm2 in untreated hypertrophic hearts) and improved global cardiac function (ejection fraction 48.9 ± 1.0% vs. 36.1 ± 1.7% in control hearts). Moreover, at d56 antimiR-132-treated hea...Continue Reading

References

Aug 3, 2005·The Journal of Clinical Investigation·Ichiro ShiojimaKenneth Walsh
Oct 17, 2007·Genes & Development·Michael PotenteStefanie Dimmeler
Nov 3, 2007·The Journal of Clinical Investigation·Daniela TirziuMichael Simons
Jul 14, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Jinqing LiTaixing Cui
Jan 11, 2011·Journal of Molecular and Cellular Cardiology·Yasuhiro MaejimaJunichi Sadoshima
May 29, 2013·International Journal of Molecular Sciences·Tilde V EskildsenSøren P Sheikh
Jul 19, 2013·The Journal of Clinical Investigation·Tilman ZieglerChristian Kupatt
Jul 25, 2013·Free Radical Biology & Medicine·Xinghua ChengRichard C M Siow
Sep 14, 2014·European Heart Journal·Regalla KumarswamyThomas Thum
Jun 6, 2016·Journal of Molecular and Cellular Cardiology·Ippei Shimizu, Tohru Minamino
Jul 23, 2016·Circulation Research·Hendrik B SagerMatthias Nahrendorf
Jan 14, 2017·Journal of the American College of Cardiology·Rabea HinkelChristian Kupatt
Mar 22, 2019·Frontiers in Cardiovascular Medicine·Rajinikanth GogirajuKatrin Schäfer
Jan 31, 2020·Cardiovascular Research·Paolo G CamiciSophie Van Linthout
Feb 2, 2020·Nature Communications·Ariana FoinquinosThomas Thum
Apr 18, 2020·Journal of the American College of Cardiology·Rabea HinkelStefan Engelhardt
Jun 28, 2020·European Journal of Heart Failure·Shinsuke YamanakaUNKNOWN CHART-2 Investigators

❮ Previous
Next ❯

Citations

Jun 12, 2021·Journal of the American College of Cardiology·Gianluigi Condorelli, Giuseppe Ferrante
Jun 23, 2021·Nature Reviews. Cardiology·Andrew Robson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.